~Awarded by Rohto Pharmaceutical to researchers with the aim of advancing obstetrics and gynecology research~
The recipients of the 17th Rohto Women's Health Science Research Award have been decided.
May 18, 2026
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, President: Hidetoshi Segi) has announced the recipients of the 17th Rohto Women's Health Research Award is given to researchers in obstetrics and gynecology. A commemorative lecture was held at a seminar co-sponsored by the 78th Annual Meeting of the Japan Society of Obstetrics and Gynecology (May 15-17, 2025, Sapporo City).
About Rohto Women's Health Research Award
It evolved from the Women's Health Science Research Association, which was established in 2009, and was founded by Rohto Pharmaceutical Co., Ltd. in 2019.
This award is given to researchers at Japanese universities and equivalent research institutions who have made outstanding contributions to obstetric and gynecological research, with the aim of promoting research on maternal health and infertility treatment, as well as research on women's health and longevity in preparation for the 100-year life era, and thereby contributing to the development and improvement of obstetric and gynecological research in Japan.
A selection committee comprised of nine academic experts in women's health research conducts a rigorous and fair review process, awarding plaques and prize money (totaling 5 million yen, 1 to 3 million yen per person) to three researchers who have conducted outstanding research.
This year, the following three researchers have received awards, and the following supplementary prizes will be presented by Rohto Pharmaceutical Co., Ltd.
17th Award Winners
| full name |
Affiliation |
Presentation title |
Second Prize |
| Yokomizo Ryo |
Tokyo Jikei University School of Medicine |
Exploring a comprehensive approach based on regenerative cell therapy technology aimed at overcoming intractable uterine infertility. |
2 million yen |
| Yusuke Matoba |
Hiroshima University |
Uterine Regenerative medicine looking ahead to the post-uterine transplant era: The potential of uterine function reconstruction using scaffold-free bio-3D printed cell layers. |
1.7 million yen |
| Naoyuki Iwahashi |
Wakayama Medical University |
Elucidating the pathogenesis of placental malformation as a protein misfold disorder and developing novel therapeutic strategies. |
1.3 million yen |